ABSTRACT
The clinical observation of the successful treatment of newly diagnosed fibro-cavernous pulmonary tuberculosis caused by mycobacteria of multidrug-resistant tuberculosis and the results of control of the effectiveness of treatment with modern high-tech radiation methods are presented. The necessity of an individual approach to the treatment of tuberculosis in this category of patients is shown.
Subject(s)
Antitubercular Agents/administration & dosage , Bronchoscopy/methods , Lung/diagnostic imaging , Mycobacterium tuberculosis , Thoracoplasty/methods , Tuberculosis, Multidrug-Resistant , Tuberculosis, Pulmonary , Adult , Antitubercular Agents/classification , Combined Modality Therapy/methods , Humans , Long-Term Care/methods , Long-Term Care/organization & administration , Male , Mycobacterium tuberculosis/isolation & purification , Mycobacterium tuberculosis/pathogenicity , Mycobacterium tuberculosis/physiology , Tomography, X-Ray Computed/methods , Treatment Outcome , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/radiotherapy , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/radiotherapyABSTRACT
We report a technique for treatment of pulmonary tuberculosis that has become resistant to traditional antibiotics. We introduce a needle into the lung that carries the N2 laser to the affected chest cavity. It is irradiated for 10 min and usually only one sitting is required. Clinical improvement occurred in 90% of the patients; 60% of the patients showed improvement on their X-rays. This technique is recommended as an adjuvant to traditional tuberculosis therapy.
